The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMpower010: Exploratory analysis of disease-free survival by KRAS status in patients with stage II-IIIA NSCLC treated with adjuvant atezolizumab vs best supportive care.
 
Martin Reck
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Samsung Bioepis; Sanofi/Regeneron
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Sanofi/Aventis
 
Minu K SRIVASTAVA
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Heather A. Wakelee
Consulting or Advisory Role - Mirati Therapeutics
Research Funding - ACEA Biosciences (Inst); Arrys Therapeutics (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Helsinn Therapeutics (Inst); Merck (Inst); Novartis (Inst); Seagen (Inst); Xcovery (Inst)
(OPTIONAL) Uncompensated Relationships - Genentech/Roche; Merck
 
Enriqueta Felip
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BerGenBio; Bristol Myers Squibb; Daiichi Sankyo Europe GmbH; F. Hoffmann LaRoche; GlaxoSmithKline; Janssen; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Peptomyc; Pfizer; Sanofi; Takeda; Turning Point Therapeutics
Speakers' Bureau - Amgen; AstraZeneca; Bristol Myers Squibb; F. Hoffmann LaRoche; Janssen; Lilly; Medical Trends; Medscape; Merck Serono; Merck Sharp & Dohme; PeerVoice; Pfizer; Sanofi; Takeda; Touch Oncology
Research Funding - Merck (Inst); Merck KGaA (Inst)
Other Relationship - GRIFOLS
 
Nasser K. Altorki
Stock and Other Ownership Interests - Angiocrine Bioscience; tomorrow; View Point Medical
Honoraria - AstraZeneca; Regeneron
Research Funding - AstraZeneca (Inst); Janssen Research & Development (Inst)
 
Tibor Csoszi
Consulting or Advisory Role - Novartis
Speakers' Bureau - Ipsen; Janssen-Cilag
Travel, Accommodations, Expenses - Pfizer; Sanofi
 
Vladimir Moiseyenko
Consulting or Advisory Role - AstraZeneca; brocade
Research Funding - Astellas Pharma; AstraZeneca; AstraZeneca; Boston Biomedical; Celltrion; Clovis Oncology; Eli Lilly & ??; Merck; Mylan; Pfizer; Roche; Samsung Bioepis; Tesaro
 
Andrey Akopov
No Relationships to Disclose
 
Alexey Smolin
Consulting or Advisory Role - AstraZeneca; BioCad; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca; Bristol-Myers Squibb; MSD; Roche
 
Antonio Chella
No Relationships to Disclose
 
Eric Vallieres
Honoraria - AstraZeneca; Bristol Myers Squibb Foundation; OncoCyte; Research to Practice; Targeted Oncology
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Olympus Medical Systems; OncoCyte
Speakers' Bureau - AstraZeneca; OncoCyte
Travel, Accommodations, Expenses - AstraZeneca; Bristol Myers Squibb Foundation
 
Alex Martinez-Marti
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; MSD Oncology; Pfizer; Roche
Speakers' Bureau - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
 
Wei Zou
Employment - roche
Stock and Other Ownership Interests - roche
Research Funding - roche
Travel, Accommodations, Expenses - roche
 
V. McNally
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Elizabeth Bennett
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Hen Prizant
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Barzin Nabet
Employment - Merck (I); Roche/Genentech
Stock and Other Ownership Interests - Merck (I); Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patents related to immunomodulatory RNA and cancer immunotherapy biomarkers.
 
Marcus Ballinger
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Barbara J. Gitlitz
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Caicun Zhou
Honoraria - Amoy Diagnostics; Anheart Therapeutics; Boehringer Ingelheim; C-STONE LUYE Pharma; Hengrui Medicine; Innovent Biologics; Lilly O.; MSD; QiLu Pharmaceutical; Roche; Sanofi; TopAlliance BioSciences Inc
Consulting or Advisory Role - Hengrui Medicine; Innovent Biologics; QiLu Pharmaceutical; Top Alliance Bioscience